Table 1.

Clinical characteristics of study participants split by race and LDLC statin response

	Caucasian American		African American
	High	Low	High	Low
N	23	21	13	18
Men	48%	62%	85%	44%
BMI	27.9 ± 6.3	27.5 ± 4.5	32.1 ± 6.6	30.2 ± 5.6
Age (yrs)	50.6 ± 12.1	52.7 ± 9.7	50.8 ± 10.5	55.1 ± 15.0
Before treatment LDLC level (mg/dl)	136 ± 34	132 ± 28	141 ± 31	122 ± 42
LDLC percent change after statin treatment (%)	-58.7 ± 4.1%	-22.0 ± 7.6%	-53.9 ± 5.7%	-26.7 ± 7.3%
LDLC level change after statin treatment (mg/dl)	-80.3 ± 22.4	-29.3 ± 12.4	-76.0 ± 18.3	-33.6 ± 16.4

Data are presented as numbers, percentages or means ± SDs. None of these participants were smokers.